Drug Database
Back to search

Netherlands· NL-37bf2e2e4d65

Tibolon BioSyent 2,5 mg tabletten

A tibolone product containing tibolon, registered in Netherlands by BioSyent Pharma Europe B.V.. The same ATC class is registered in 16 of our 19 countries.

ATC G03CX01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedTibolon BioSyent 2,5 mg tablettenATCG03CX01REGISTER NO.NL-37bf2e2e4d65PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about tibolonAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Tibolone is registered in 16 of 19 countries.

Countries holding a registration under ATC G03CX01 (tibolone), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 9 of them publish a price we can compare per daily dose
Search tibolone products by name

Tibolone · ATC G03CX01

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of tibolone costs, country by country.

Normalised to the WHO defined daily dose (2.5 mg), the median price runs from $0.39 in Italy to $0.95 in Switzerland — a ×2.4 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Tibolone · price per daily dose (2.5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.95
  • IT Italy$0.39
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
TIBOLON
Manufacturer
BioSyent Pharma Europe B.V.
Country
Netherlands (NL)
ATC code
G03CX01
ATC class
Tibolone
Defined daily dose
2.5 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    117126

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Tibolone in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tibolone products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Liviel, Tiloria
  • Belgium · Heria, Livial
  • Bulgaria · Айвиал, Ливиал
  • Cyprus · Livial
  • Czechia · Ladybon, Livial
  • Germany · Liviella, Tibolon Aristo
  • Denmark · Livial, Tibocina
  • Spain · Boltin, Tibicare
  • Finland · Livial, Tibocina
  • France · Livial, Tibolone Ccd
  • United Kingdom (Northern Ireland) · Livial, Tibolone Aristo Pharma Gmbh
  • Greece · Juliette, Livial
  • Hungary · Ladybon, Livial
  • Ireland · Livial, Tibolone Aristo
  • Iceland · Livial
  • Italy · Livial, Menec
  • Lithuania · Livial
  • Luxembourg · Heria, Livial
  • Norway · Livial, Tibocina
  • Poland · Ladybon, Livial
  • Portugal · Clitax, Goldar
  • Romania · Livial
  • Sweden · Livial, Tibelia
  • Slovenia · Livial
  • Slovakia · Ladybon, Livial

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f7ca1d21-ea03-4c86-a3ea-7ca8629d7e47
GET /v1/drugs/f7ca1d21-ea03-4c86-a3ea-7ca8629d7e47?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h117126_smpc.pdf",
  "strength": null,
  "atc_label": "Tibolone",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg117126",
  "excipients": [
    "AARDAPPELZETMEEL",
    "ASCORBYLPALMITAAT (E 304)",
    "LACTOSE 1-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MANNITOL (D-) (E 421)"
  ],
  "substances": [
    "TIBOLON"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h117126.pdf",
  "authorised_at": "2016/05/25",
  "procedure_number": "BE/H/0310/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "117126",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about tibolone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console